- Home
- MOLN vs TWIN Comparison
MOLN vs TWIN Comparison
Compare MOLN & TWIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MOLN | TWIN |
|---|---|---|
| Founded | 2004 | 1918 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | | Industrial Machinery/Components |
| Sector | | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 157.8M | 224.5M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | MOLN | TWIN |
|---|---|---|
| Price | $4.39 | $15.27 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $3.75 | ★ $12.00 |
| AVG Volume (30 Days) | 3.4K | ★ 24.0K |
| Earning Date | 10-30-2025 | 02-04-2026 |
| Dividend Yield | N/A | ★ 1.02% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.02 |
| Revenue | N/A | ★ $347,837,000.00 |
| Revenue This Year | N/A | $10.79 |
| Revenue Next Year | $1,000.00 | $8.43 |
| P/E Ratio | ★ N/A | $632.99 |
| Revenue Growth | N/A | ★ 14.24 |
| 52 Week Low | $3.36 | $6.16 |
| 52 Week High | $5.91 | $17.08 |
Technical Indicators
Market Signals| Indicator | MOLN | TWIN |
|---|---|---|
| Relative Strength Index (RSI) | 55.40 | 49.49 |
| Support Level | $3.98 | $15.28 |
| Resistance Level | $4.40 | $15.84 |
| Average True Range (ATR) | 0.18 | 0.52 |
| MACD | -0.01 | -0.03 |
| Stochastic Oscillator | 68.12 | 38.89 |
Price Performance
Historical ComparisonAbout MOLN Molecular Partners AG
Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.
About TWIN Twin Disc Incorporated
Twin Disc Inc is a United States-based firm engaged in the manufacture and sale of marine and heavy-duty off-highway power transmission equipment. The company operates its business through two reportable segments: Manufacturing and Distribution. Its product portfolio includes marine transmissions, surface drives, propellers, and boat management systems as well as power-shift transmissions, hydraulic torque converters, power take-offs, industrial clutches, and control systems.